GUILFORD, Conn.–(BUSINESS WIRE)– #theproteinsequencingcompany–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will be presenting a poster on a new method for detection of arginine post-translational modifications (PTMs) using Platinum™, the world’s first next-generation single-molecule protein sequencing platform, at the American Association for Cancer Research’s (AACR) Annual Meeting 2023. The conference will take place April 14-19, 2023 at My Business Wire News
